BASEL, Switzerland–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s expansion in vendor-agnostic scientific software, R&D and QC digitalization,... Read more
ANDOVER, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (Nasdaq: MKSI), a global provider of technologies that transform our world, recently received the 2023 Outstanding Service Award from MFLEX, a global leader in flexible printed circuit board manufacturing and assembly. Read more
Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024 WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen Health Care Conference on Wednesday, March... Read more
ELITechGroup is a differentiated, fast growing and profitable systems and assay provider for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology ELITechGroup offers the proprietary, fully automated sample-to-answer (S2A) molecular diagnostic (MDx) systems InGenius® and BeGenius® for mid-sized hospitals and esoteric testing Large and diversified ELITech MDx assay portfolio is focused on pathogens and viral... Read more
WASHINGTON, Feb. 27, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 5, 2024 at 11:10 a.m. ET. The event will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a leading global... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences: Citi 2024 Unplugged Medtech and Life Sciences Access Day in New York City Thursday, February 29, 2024, at 8:45 a.m. Eastern Time TD Cowen 44th Annual... Read more
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets WASHINGTON, Feb. 22, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 15, 2024 to stockholders of record as of March 1, 2024. About Bruker Corporation... Read more
Q4 2023 revenues of $854.5 million, up 20.6% year-over-year (yoy); organic revenue up 15.9% yoy Q4 2023 GAAP EPS of $1.41, including a $0.99 per share gain on PhenomeX acquisition[1]; Q4 2023 non-GAAP EPS of $0.70, down 5.4% yoy; pro forma non-GAAP EPS excluding PhenomeX acquisition up 8.1% yoy Full year 2023 revenues of $2.96... Read more
Quarterly revenue of $893 million, exceeding the high-end of guidance Quarterly GAAP net loss of $68 million and net loss per share of $1.02, which includes goodwill and intangible asset impairments Quarterly Non-GAAP net earnings per diluted share of $1.17 and Adjusted EBITDA of $218 million, Read more